REAX · Real REMAX Group Inc.
Real REMAX Group Inc. (REAX)
What's happening
- REAX is down 14.29% today, trading at $12.66. — Live quote
- It's trading within 3% of its 52-week low ($12.35). (Finnhub fundamentals)
- Volume today (106,323) is well below its 3-month average of 720,070. (Finnhub fundamentals)
- Last quarter's EPS missed estimates: $-2.02 actual vs. $0.09 estimated (-2403.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-11-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 31.5% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-11-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -0.7%. Finnhub fundamentals ↗
- Trailing 52-week price return is -65.1%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on REAX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '26 | Sep '25 |
|---|---|---|
| Revenue | $727.9M | $568.5M |
| Gross profit | $81.8M | $44.9M |
| Operating income | -$72.0M | -$473.0K |
| Net income | -$67.3M | -$447.0K |
| EPS (diluted) | $-2.25 | $-0.02 |
| EPS (basic) | $-2.25 | $-0.02 |
| Operating margin | -$10 | -$0 |
| Net margin | -$9 | -$0 |
Balance sheet
| Line item | Sep '26 | Dec '25 | Dec '24 |
|---|---|---|---|
| Total assets | $1.15B | $126.8M | — |
| Total liabilities | $732.7M | $75.2M | — |
| Stockholders' equity | $414.8M | $51.7M | — |
| Total current assets | $266.2M | $105.7M | — |
| Total current liabilities | $230.3M | $75.2M | — |
| Cash & equivalents | $102.5M | $33.2M | — |
| Marketable securities (current) | $6.9M | $16.7M | — |
| Other current assets | $901.0K | $543.0K | — |
| Marketable securities (non-current) | $3.1M | $2.2M | — |
| Property, plant & equipment | $5.5M | $758.0K | — |
| Goodwill | $336.9M | $9.0M | — |
| Intangible assets | $507.3M | $5.9M | $4.2M |
| Other non-current assets | $465.0K | — | — |
| Accounts payable | $4.9M | $1.2M | — |
| Accrued liabilities | $112.9M | $38.2M | — |
| Deferred revenue (current) | $20.7M | — | — |
| Short-term debt | $30.9M | — | — |
| Other current liabilities | $8.8M | $9.5M | — |
| Long-term debt | $482.6M | — | — |
| Other non-current liabilities | $2.4M | — | — |
| Common stock & paid-in capital | $38.0K | $21.0K | — |
| Retained earnings | -$191.6M | -$112.9M | — |
| Accumulated other comprehensive income (loss) | $1.2M | $318.0K | — |
Cash flow
| Line item | Sep '26 | Sep '25 |
|---|---|---|
| Operating cash flow | $14.5M | $65.8M |
| Investing cash flow | -$393.4M | -$16.0M |
| Financing cash flow | $484.5M | -$24.8M |
| Free cash flow | $14.2M | $64.8M |
| Capital expenditures | $239.0K | $935.0K |
| Depreciation & amortization | $4.7M | $1.3M |
| Share-based compensation | $88.4M | $50.4M |
| Deferred income taxes | -$16.9M | — |
| Purchases of investments | $11.7M | $15.8M |
| Share repurchases | $4.7M | $24.3M |
| Debt repaid | $25.0M | — |
| Tax withholding on stock comp | $17.2M | $2.0M |
Income statement
Balance sheet
Cash flow
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding REAX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-08-24 to 2026-10-08
Recent transactions
- Insiders have net sold 52,876 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: Pozek Ken (Reporting person) — Grant / award of 3 shares on 2026-10-08.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Pozek Ken | Reporting person | Grant / award | 2026-10-08 | 3 |
| Liniger David L. | 10% owner | Acquired/disposed by will or inheritance | 2026-09-24 | 6,742 |
| Lumpkin Alexandra | Chief Legal Officer | Option exercise | 2026-09-17 | 302 |
| Rozenblat Jenna | President | Option exercise | 2026-09-17 | 417 |
| Damani Pritesh | Chief Technology Officer | Option exercise | 2026-09-13 | 1,285 |
| Poleg Tamir | Chief Executive Officer | Option exercise | 2026-09-13 | 5,392 |
| Carlson Erik | Director | Grant / award | 2026-09-01 | 601,998 |
| Jani Ravi | Chief Financial Officer | Option exercise | 2026-09-01 | 437 |
| Jenkins Norman K. | Director | Grant / award | 2026-08-24 | 13,750 |
| Jenkins Leah R | Chief Accounting Officer | Grant / award | 2026-08-24 | 10,079 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-08 | Pozek Ken | Reporting person | Grant / award | 3 | $0.00 |
| 2026-09-24 | Liniger David L. | 10% owner | Acquired/disposed by will or inheritance | 6,742 | $0.00 |
| 2026-09-24 | Liniger David L. | 10% owner | Gift | 6,742 | $0.00 |
| 2026-09-17 | Liniger David L. | 10% owner | Open market sale | 52,876 | $19.12 |
| 2026-09-17 | Lumpkin Alexandra | Chief Legal Officer | Option exercise | 302 | $0.00 |
| 2026-09-17 | Rozenblat Jenna | President | Option exercise | 417 | $0.00 |
| 2026-09-13 | Lumpkin Alexandra | Chief Legal Officer | Option exercise | 304 | $0.00 |
| 2026-09-13 | Rozenblat Jenna | President | Option exercise | 914 | $0.00 |
| 2026-09-13 | Damani Pritesh | Chief Technology Officer | Option exercise | 1,285 | $0.00 |
| 2026-09-13 | Poleg Tamir | Chief Executive Officer | Option exercise | 5,392 | $0.00 |
| 2026-09-10 | Damani Pritesh | Chief Technology Officer | Option exercise | 884 | $0.00 |
| 2026-09-10 | Poleg Tamir | Chief Executive Officer | Option exercise | 4,102 | $0.00 |
| 2026-09-10 | Rozenblat Jenna | President | Option exercise | 1,029 | $0.00 |
| 2026-09-10 | Lumpkin Alexandra | Chief Legal Officer | Option exercise | 593 | $0.00 |
| 2026-09-01 | Carlson Erik | Director | Grant / award | 601,998 | — |
| 2026-09-01 | Carlson Erik | Director | Tax withholding | 263,369 | — |
| 2026-09-01 | Jani Ravi | Chief Financial Officer | Option exercise | 437 | $0.00 |
| 2026-08-24 | Jenkins Norman K. | Director | Grant / award | 13,750 | — |
| 2026-08-24 | Jenkins Norman K. | Director | Grant / award | 5,348 | — |
| 2026-08-24 | Jenkins Leah R | Chief Accounting Officer | Grant / award | 10,079 | — |
| 2026-08-24 | Jenkins Leah R | Chief Accounting Officer | Grant / award | 5,348 | — |
| 2026-08-24 | Carlson Erik | Director | Grant / award | 98,031 | — |
| 2026-08-24 | Carlson Erik | Director | Grant / award | 770,844 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-08 22:53 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-11-05 | 10-Q | 2026-09-30 | View on SEC.gov → |
| 2026-11-05 | 8-K | 2026-11-05 | View on SEC.gov → |
| 2026-10-27 | 4 | 2026-10-08 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-21 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-13 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-13 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-13 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-13 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-09-10 | View on SEC.gov → |
Recent news
Headlines about REAX (Real REMAX Group Inc.). Links open the publisher — we don’t host full articles.
-
Real REMAX Group (Nasdaq:REAX) - Stock Analysis
Simply Wall St · 2026-11-08 -
The Real Brokerage Stock Price Forecast. Should You Buy REAX?
StockInvest.us · 2026-11-06 -
Real REMAX Group Inc. (REAX) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-11-06 -
Real REMAX Group Q3 Earnings Call Highlights
Yahoo · 2026-11-06 -
REAX Maintained by BTIG -- Price Target Lowered to $25.00
GuruFocus · 2026-11-05 -
Jones Trading Maintains Buy on Real REMAX Group, Lowers Price Target to $25.75
Benzinga · 2026-11-05 -
Real REMAX projects $175M-$190M 2027 adjusted EBITDA as it targets $30M+ synergy capture
Seeking Alpha · 2026-11-05 -
Real REMAX (REAX) Q3 2026 Earnings Call Transcript
Yahoo · 2026-11-05
No headlines in this category right now — try “All”.